Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,475.53
    -1,013.21 (-1.97%)
     
  • CMC Crypto 200

    1,320.95
    -75.59 (-5.41%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Hofseth Biocare ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a contemplated subsequent offering (the "Subsequent Offering").

Date on which the terms of the Subsequent Offering was announced:

16 October 2020

Last day including right:

15 October 2020

First day excluding right:

16 October 2020

Record date:

19 October 2020

EGM date:

On or about 11 November 2020

Maximum number of new shares:

4,938,271

Subscription price:

NOK 8.10

Shall the rights be listed

No

This information is published in accordance with the requirements of the Continuing Obligations.